Professionals in the animal health space want advice they can trust. The sector’s role in addressing the One Health agenda is growing in both visibility and impact, and animal pharmaceutical companies are ideally positioned to provide access to research and resources. By being a source of trusted, strategic information, animal pharma brands can be practical partners to vets, and advance the cause of protecting not just animals, but people and the planet.

The green transition industry has suffered a number of blows in 2025, slowing progress. But whilst the opportunities for growth (and the paths to get there) may have changed, they are still abundant. In our new reality, strategic storytelling is an incredibly powerful tool to inspire the confidence the market needs to move forward.

As brands battle to win out in the attention economy and grapple with the rise of GenAI, creating content that really resonates is a confounding challenge. FSC’s new white paper unpacks the seismic shifts in today’s content ecosystem, looks at what’s next – and offers a roadmap for businesses ready to lead with creativity, clarity and credibility.

Innovation may be at the heart of the green transition, but how that innovation is communicated – across every channel, to every stakeholder – is fast becoming a defining advantage. This is where content plays a crucial and often very underestimated role.

Misinformation and skepticism are holding back progress in the animal pharmaceutical industry. But what if patient success stories, expert interviews, and interactive educational tools could change that? FSC discusses how strategic, editorially-led content can foster trust, engage pet owners, and improve health outcomes for animals everywhere.